%20(2).png){kind=logo}
.jpg)
As of October 1, 2024, pharmaceutical companies promoting prescription medicines in the UK must adhere to the revised standards outlined in the new Association of the British Pharmaceutical Industry (ABPI) 2024 Code of Conduct.
In the global fight against HIV, a twice-yearly injection could represent a seismic shift in prevention efforts.
The Healthcare Technology Report has recognized Ostro as one of the Top 100 Healthcare Technology Companies of 2024.
Is time spent on your website a sign of engagement or frustration? For pharma brands, recognizing the difference between productive and non-productive actions is crucial to driving meaningful engagement.
At Ostro, we don’t make new medicines, but we like to say that our talent is making medicine make sense.
The pharma sector faces a critical challenge: bridging the widening digital divide. To keep pace with rapid technological advancements, companies need to break down silos and integrate their digital initiatives, ensuring a seamless and effective approach to innovation.
As an industry, we owe it to our stakeholders—and most importantly, to the patients and providers that we support—to innovate and improve while remaining legally compliant.
On its 10th anniversary, Exact Sciences' Cologuard, a noninvasive, at-home alternative to colonoscopy, is a prime example of how consumerization can apply to diagnostics.
%20(1).png)
By actively addressing misinformation and meeting patients where they are in their patient journey, pharmaceutical companies not only protect their brand and reputation but also contribute to the broader goal of safeguarding public health.
.svg)